GMR Solutions Inc. reported revenue of $1,595.6 million, up 5.9%, and net income of $135.6 million, up 81.7%, for the three months ended September 30, 2026.
GMRS · GMR Solutions Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Short volume, last session
- 45%
- Last earnings
- Nov 10, 2026
- Latest filing
- 10-Q · Nov 9
- Price history
- May 2026 to Nov 2026
The closing range uses available history since May 13, 2026; less than a full year is stored.
Up next
Latest documents
GMR Solutions Inc. reported third-quarter revenue of $1,595.6 million, up 5.9%, and net income of $135.6 million, up 81.7%, through September 30, 2026. Full-year 2026 guidance: revenue of $5,900 million–$6,050 million and Adjusted EBITDA of $1,135 million–$1,195 million.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
AI Brief
Q2 FY26 earnings call · Aug 13, 2026TL;DR. GMR Solutions reported Q2 2026 revenue up 3.3% to $1.49B with adjusted EBITDA down 11.8% to $284.5M (largely due to a $74M prior-year NSA estimate comp and ~$16M ACA exchange payer-mix headwind), a swing to a $28.3M net loss driven by $142.3M of IPO-related expenses, and reaffirmed full-year guidance while flagging continued Iran-conflict fuel/cost pressure.
- + Q2 revenue grew 3.3% YoY to $1,490.3M with continued momentum in emergent services
- + Liquidity strengthened with $420M cash and ~$696M undrawn ABL capacity following IPO capital actions and credit rating upgrade
- + Net leverage already at 3.5x (down from 4.3x) with line of sight to below 3.3x by year-end and 3.0x by end of 2027
- + 911 Nurse Navigation scaled to 29 communities / 19.7M covered lives with calls up 50% YoY and four more implementations planned
- − Adjusted EBITDA fell 11.8% YoY to $284.5M as margin pressure from ACA exchange subsidy expiration and higher costs weighed on results
- − Net loss of $28.3M in Q2 vs. $80.8M net income prior year, driven by $142.3M of IPO-related stock comp and professional fees
- − Total operating expense rose 19.4% YoY to $1.43B, with employee wages up 24.5% and fuel/maintenance up 21.1% on Iran-conflict and aircraft maintenance timing
- − CapEx and aircraft financing stepped up to 6.3% of revenue vs. 4.5% prior year due to pull-forward of purchases
- − Year-over-year No Surprises Act/IDR revenue estimate tailwind was $74M lower, creating a meaningful comparability drag
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $1.81 | Nine months ended September 30, 2026 | +4.0% |
|
|
|||
| Adjusted EBITDA non-GAAP | $946.15M | nine months ended September 30, 2026 | — |
|
|
|||
| Air base count | 386 | three months ended September 30, 2026 | — |
|
|
|||
| Cash used in aircraft financing arrangements (in thousands) | $79.96M | nine months ended September 30, 2026 | — |
|
|
|||
| Commercial insurance and managed care | 57% | Three Months Ended September 30, 2026 filing | — |
| EBITDA | 776.63M | Nine Months Ended September 30, 2026 | — |
|
|
|||
| Emergent air transport requests | 239,916 | nine months ended September 30, 2026 | — |
|
|
|||
| Emergent transports | 2,557,487 | nine months ended September 30, 2026 | — |
|
|
|||
| Flights | 108,233 | nine months ended September 30, 2026 | — |
|
|
|||
| Ground transports | 3,060,386 | nine months ended September 30, 2026 | — |
|
|
|||
| Lender Defined Adjusted EBITDA non-GAAP | 361M | the three months ended September 30, 2026 filing | — |
|
|
|||
| Medicaid | 9% | the three months ended September 30, 2026 filing | — |
| Medicare | 25% | the three months ended September 30, 2026 filing | — |
| Net cash capital expenditures (in thousands) | $175.11M | nine months ended September 30, 2026 | — |
|
|
|||
| Net transport revenue per ambulance transport | $1,386 | nine months ended September 30, 2026 | — |
|
|
|||
| Non emergent transports | 611,132 | nine months ended September 30, 2026 | — |
|
|
|||
| Non-emergent transports | 203,894 | Three Months Ended September 30, 2026 filing | — |
| Non-transport | 835,832 | nine months ended September 30, 2026 | — |
|
|
|||
| Nurse Navigation encounters | 89,211 | nine months ended September 30, 2026 | — |
|
|
|||
| Other third-party payors | 8% | Three Months Ended September 30, 2026 filing | — |
| Same market revenue growth | 5.8% | nine months ended September 30, 2026 | — |
|
|
|||
| Self-pay | 1% | Three Months Ended September 30, 2026 filing | — |
| Total ambulance transports | 3,168,619 | nine months ended September 30, 2026 | — |
|
|
|||
| Total patient encounters | 4,114,802 | nine months ended September 30, 2026 | — |
|
|
|||
| Weather cancellation rate for emergent air transports | 16.1% | nine months ended September 30, 2026 | — |
|
|
|||
| Wheelchair transports | 21,140 | nine months ended September 30, 2026 | — |
|
|
|||
| net revenue per transport | 7.9% | the three months ended March 31, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GMRS
this stock
GMR Solutions Inc.
|
$674.99M | — | — | — | 7.1% |
|
HCA
HCA Healthcare, Inc.
|
$99.34B | +1.9% | +7.1% | 15.8 | 2.3% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$31.59B | -2.2% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.95B | +32.4% | +0.9% | 7.6 | 2.2% |
|
EHC
Encompass Health Corp
|
$13.11B | +25.9% | +10.5% | 20.9 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GMRS | -12.3% | -5.7% | -4.6% | -9.6% | — |
| SPY | -8.6% | -9.2% | -9.2% | -8.7% | +1.2% |
| vs SPY | -3.8% | +3.6% | +4.6% | -0.8% | — |